Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Echocardiography and Cardiopulmonary Exercise Testing for Early Detection of Pulmonary Hypertension in Primary Myelofibrosis

Alessandra Iurlo, MD PhD, Mariarita Sciumè, MD, Veronica Mattiello, MD, Daniele Cattaneo, MD, Nicola Orofino, MD, Ivan Cortinovis, Umberto Gianelli, MD, Alberto Pierini, MD, Agostino Cortelezzi, MD

Blood (2015) 126 (23): 4066.

https://doi.org/10.1182/blood.V126.23.4066.4066

Published: 2015

Journal Articles

Final Results of a Phase 1 Study of 18F-FLT Positron Emission Tomography (PET)/Computed Tomography Imaging in Myelofibrosis ( FLT-MF-2009 Study)

Annalisa Andreoli, MD, Laetitia Vercellino, MD, Matthieu John Ouvrier, MD, Emmanuelle Barré, PharmD, Bruno Cassinat, PharmD, PhD, Virginie de Beco, PharmD, Pascal Merlet, MD PhD, Christine Dosquet, MD PhD, Christine Chomienne, MD PhD, Sylvie Chevret, MD PhD, Marie-Elisabeth Toubert, MD, Jean-Jacques Kiladjian, MD PhD

Blood (2014) 124 (21): 3195.

https://doi.org/10.1182/blood.V124.21.3195.3195

Published: 2014

Journal Articles

The Role Of p53 In JAK2V617F-Induced Myeloproliferative Neoplasms

Wanke Zhao, Yanhong Du, Yun Chen, Wanting Ho, Zhizhuang Joe Zhao, PhD

Blood (2013) 122 (21): 4103.

https://doi.org/10.1182/blood.V122.21.4103.4103

Published: 2013

Journal Articles

18 F-FLT Positron Emission Tomography (PET)/CT Imaging in Myelofibrosis: A Non Invasive Method to Assess Bone Marrow Function and Extramedullary Hematopoiesis

Annalisa Andreoli, MD, Laetitia Vercellino, Mathieu-John Ouvrier, Emmanuelle Barré, Bruno Cassinat, PharmD, PhD, Virginie de Beco, Jean-Marc Zini, MD, PhD, Pascal Merlet, MD, Christine Dosquet, MD, Christine Chomienne, MD, PhD, Marie-Elisabeth Toubert, Jean-Jacques Kiladjian, MD, PhD

Blood (2012) 120 (21): 1741.

https://doi.org/10.1182/blood.V120.21.1741.1741

Published: 2012

Journal Articles

A Case of Massive Intracerebral Haemorrage in Advanced Myelofibrosis Due to Atypical Metaplasia.

Marianna Caramella, Cristina Gabutti, Cecilia Del Curto, Cristina Campidelli, Guido Nador, Ester Pungolino, Enrica Morra, MD

Blood (2009) 114 (22): 4988.

https://doi.org/10.1182/blood.V114.22.4988.4988

Published: 2009

Journal Articles

Coexistence Between Chronic Myeloproliferative Syndrome and Chronic Lymphoproliferative Syndrome: Report of 4 Cases

Marina Huber, MD, Veronica Susana Montero, PHD, Dardo Riveros, MD, Guy Garay, MD, Jose Fernandez, MD, Juan Dupont, MD, Roberto Cacchione, MD

Blood (2008) 112 (11): 5258.

https://doi.org/10.1182/blood.V112.11.5258.5258

Published: 2008

Journal Articles

Loss of Heterozygosity of Chromosome 1p34 and High Mutant Allele Burden in Patients with Post-Essential Thrombocythemia Myelofibrosis Carrying Somatic Mutations of MPL

Daniela Pietra, Elisa Rumi, MD, Angela Brisci, Francesco Passamonti, MD, Sabrina Boggi, Laura Cremonesi, Mario Lazzarino, MD, Mario Cazzola

Blood (2008) 112 (11): 176.

https://doi.org/10.1182/blood.V112.11.176.176

Published: 2008

Journal Articles

Additon of Low-Dose Interferon-alpha (LD-IFN-a) and Lenalidomide after Failure to a Combination of Thalidomide and Prednisone in Myelofibrosis with Myeloid Metaplasia (MMM).

Lisa Reale, MD, Emmanuel C. Besa, M.D.

Blood (2007) 110 (11): 4645.

https://doi.org/10.1182/blood.V110.11.4645.4645

Published: 2007

Journal Articles

Enhanced HDAC (Histone Deacetylase) Enzyme Activities in Blood CD 34 + Cells in Patients with Myeloid Metaplasia Myelofibrosis (MMM).

Jen-Chin Wang, MD, Chi Chen, MD, Ph..D, Theresa Dumlao, MD, Thong Chang, MD, Yng-Li Xiao, PhD, Inna Sominsky, MD, Jack Burton, MD

Blood (2007) 110 (11): 4657.

https://doi.org/10.1182/blood.V110.11.4657.4657

Published: 2007

Journal Articles

A Pilot Study of Treatment with Mesterlone, Prednisone and Low-Dose Thalidomide for Patients with Myelodysplastic Syndromes.

Alvaro Aguayo, MD, Eunice Garcia-Alvarez, M.D., Erick Crespo-Solis, M.D., Deborah Martinez-Banos, M.D., Xavier Lopez-Karpovitch, M.D.

Blood (2007) 110 (11): 4598.

https://doi.org/10.1182/blood.V110.11.4598.4598

Published: 2007

Journal Articles

Refractory Hemorrhagic Cystitis after Hematopoeitic Stem Cell Transplantation: Clinical Benefit of Factor XIII.

N. Chaumard, F. Legrand, F. Larosa, Eric Deconinck

Blood (2007) 110 (11): 4935.

https://doi.org/10.1182/blood.V110.11.4935.4935

Published: 2007

Journal Articles

Clinical Significance of JAK2 V617F Homozygosity in the Chronic Myeloproliferative Disorders. A Study on 1306 Patients.

Alessandro M. Vannucchi, MD, Giovanni Barosi, MD, Alessandro Rambaldi, MD, Roberto Marchioli, MD, Tiziano Barbui, MD, for the GIMEMA MPD, WP

Blood (2006) 108 (11): 664.

https://doi.org/10.1182/blood.V108.11.664.664

Published: 2006

Journal Articles

Phenotypic Differences amongst Subgroups of Patients with Myelofibrosis with Myeloid Metaplasia (MMM): Analysis of 458 MMM Patients.

Ruben Mesa, MD, Joyce Niblack, JD, Srdan Verstovsek, MD, Sunni Barnes, PhD, Angelina Tan, Pamela Atherton, Jeffrey Sloan, PhD, Ayalew Tefferi, MD

Blood (2006) 108 (11): 4878.

https://doi.org/10.1182/blood.V108.11.4878.4878

Published: 2006

Journal Articles

PTK787/ZK 222584 (PTK/ZK), an Oral Tyrosine Kinase Inhibitor, Has Activity in Patients with Agnogenic Myeloid Metaplasia (AMM).

Francis J. Giles, MD, Michael Carroll, MD, Alan List, MD, Alessandra Ferrajoli, MD, Deborah Thomas, MD, Jorge Cortes, MD, Eric Feldman, MD, Gail Roboz, MD

Blood (2006) 108 (11): 4920.

https://doi.org/10.1182/blood.V108.11.4920.4920

Published: 2006

Journal Articles

Presence of Unfavorable Cytogenetic Abnormalities Is the Strongest Predictor of Poor Survival in Secondary Myelofibrosis.

David Dingli, MD, PhD, Schwager M. Schwager, Mesa A. Ruben, MD, Chin Yang Li, MD, Ayalew Tefferi, MD

Blood (2005) 106 (11): 2585.

https://doi.org/10.1182/blood.V106.11.2585.2585

Published: 2005

Journal Articles

High Circulating CD34 Cells, Dacrocytes, Clonal Hematopoiesis, and JAK 2 Mutation Differentiate Secondary Myelofibrosis Associated with Pulmonary Hypertension from Myelofibrosis with Myeloid Metaplasia.

Uday Popat, MD, Enli Liu, MD, Yongli Guan, Josef T. Prchal, MD

Blood (2005) 106 (11): 2589.

https://doi.org/10.1182/blood.V106.11.2589.2589

Published: 2005

Journal Articles

The JAK2 V617F Tyrosine Kinase Mutation in Myelofibrosis with Myeloid Metaplasia: Clinical Correlates and Prognostic Relevance in 157 Patients.

Ayalew Tefferi, MD, Terra L. Lasho, MT, ASCP, Susan M. Schwager, David P. Steensma, MD, Ruben A. Mesa, MD, Chin Yang Li, MD, Martha Wadleigh, MD, D. Gary Gilliland, PhD, MD

Blood (2005) 106 (11): 3502.

https://doi.org/10.1182/blood.V106.11.3502.3502

Published: 2005

Journal Articles

Increased Expression of CD47 Is a Constant Marker in Mouse and Human Myeloid Leukemias.

Catriona Jamieson, Sidd Jaiswal, David Traver, Jason Gotlib, Mark Chao, Irving L. Weissman

Blood (2005) 106 (11): 3260.

https://doi.org/10.1182/blood.V106.11.3260.3260

Published: 2005

Journal Articles

Glivec/STI571 Treatment Stimulates Megakaryopoiesis and Normalizes PDGF Receptor beta Kinase Expression in Thrombocytopenic Patients with Myeloid Metaplasia with Myelofibrosis.

Marie Caroline le Bousse-Kerdiles, Christophe Desterke, Bernadette Guerton, Denis Clay, Hans Hasselbalch, Heinz Gisslinger, Jurgen Thiele, Hans Kvasnicka, Giovanni Barosi

Blood (2005) 106 (11): 2599.

https://doi.org/10.1182/blood.V106.11.2599.2599

Published: 2005

Journal Articles

Myelofibrosis in a Patient with Sarcoidosis.

Elham Abbasi, MD, Enli Liu, MD, Martha P. Mims, MD, Phd, Mark M. Udden, MD

Blood (2005) 106 (11): 4965.

https://doi.org/10.1182/blood.V106.11.4965.4965

Published: 2005

NARROW

Echocardiography and Cardiopulmonary Exercise Testing for Early Detection of Pulmonary Hypertension in Primary Myelofibrosis

Final Results of a Phase 1 Study of 18F-FLT Positron Emission Tomography (PET)/Computed Tomography Imaging in Myelofibrosis ( FLT-MF-2009 Study)

The Role Of p53 In JAK2V617F-Induced Myeloproliferative Neoplasms

18 F-FLT Positron Emission Tomography (PET)/CT Imaging in Myelofibrosis: A Non Invasive Method to Assess Bone Marrow Function and Extramedullary Hematopoiesis

A Case of Massive Intracerebral Haemorrage in Advanced Myelofibrosis Due to Atypical Metaplasia.

Coexistence Between Chronic Myeloproliferative Syndrome and Chronic Lymphoproliferative Syndrome: Report of 4 Cases

Loss of Heterozygosity of Chromosome 1p34 and High Mutant Allele Burden in Patients with Post-Essential Thrombocythemia Myelofibrosis Carrying Somatic Mutations of MPL

Additon of Low-Dose Interferon-alpha (LD-IFN-a) and Lenalidomide after Failure to a Combination of Thalidomide and Prednisone in Myelofibrosis with Myeloid Metaplasia (MMM).

Enhanced HDAC (Histone Deacetylase) Enzyme Activities in Blood CD 34 + Cells in Patients with Myeloid Metaplasia Myelofibrosis (MMM).

A Pilot Study of Treatment with Mesterlone, Prednisone and Low-Dose Thalidomide for Patients with Myelodysplastic Syndromes.

Refractory Hemorrhagic Cystitis after Hematopoeitic Stem Cell Transplantation: Clinical Benefit of Factor XIII.

Clinical Significance of JAK2 V617F Homozygosity in the Chronic Myeloproliferative Disorders. A Study on 1306 Patients.

Phenotypic Differences amongst Subgroups of Patients with Myelofibrosis with Myeloid Metaplasia (MMM): Analysis of 458 MMM Patients.

PTK787/ZK 222584 (PTK/ZK), an Oral Tyrosine Kinase Inhibitor, Has Activity in Patients with Agnogenic Myeloid Metaplasia (AMM).

Presence of Unfavorable Cytogenetic Abnormalities Is the Strongest Predictor of Poor Survival in Secondary Myelofibrosis.

High Circulating CD34 Cells, Dacrocytes, Clonal Hematopoiesis, and JAK 2 Mutation Differentiate Secondary Myelofibrosis Associated with Pulmonary Hypertension from Myelofibrosis with Myeloid Metaplasia.

The JAK2 V617F Tyrosine Kinase Mutation in Myelofibrosis with Myeloid Metaplasia: Clinical Correlates and Prognostic Relevance in 157 Patients.

Increased Expression of CD47 Is a Constant Marker in Mouse and Human Myeloid Leukemias.

Glivec/STI571 Treatment Stimulates Megakaryopoiesis and Normalizes PDGF Receptor beta Kinase Expression in Thrombocytopenic Patients with Myeloid Metaplasia with Myelofibrosis.

Myelofibrosis in a Patient with Sarcoidosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only